Publication Name	World Journal of Hepatology
Manuscript ID	7858
Country	Greece

Received	2013-12-04 08:03
Peer-Review Started	2013-12-04 17:41
To Make the First Decision	2014-02-27 11:31
Return for Revision	2014-03-03 18:02
Revised	2014-03-10 21:53
Second Decision	2014-04-16 16:01
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2014-04-16 16:07
Articles in Press	2014-05-27 10:39
Publication Fee Transferred
Edit the Manuscript by Language Editor	2014-04-23 00:05
Typeset the Manuscript	2014-05-19 10:59
Publish the Manuscript Online	2014-05-27 11:34

ISSN	1948-5182 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Review
Article Title	Μanagement of patients with hepatitis B and C before and after liver and kidney transplantation
Manuscript Source	Invited Manuscript
All Author List	Chrysoula Pipili and Evangelos Cholongitas
Funding Agency and Grant Number
Corresponding Author	Evangelos Cholongitas, Assistant Professor of Internal Medicine, Medical School of Aristotle University, Hippokration General Hospital of Thessaloniki, 49, Konstantinopoleos Street, 54642 Thessaloniki, Greece. cholongitas@yahoo.gr
Key Words	Liver transplantation; Kidney transplantation; Hepatitis C; Hepatitis B; Recurrence
Core Tip	While nucleos(t)ide analogs (NAs) offer a benign course in patients with hepatitis B virus before and after liver and renal transplantation, there is still scope for improvement. The administration of high genetic barrier NAs such as entecavir or tenofovir pre-transplant and the careful patient selection for hepatitis virus immunoglobulin-free regimens post-transplant contribute to improved medical care and facilitate its provision from a practical standpoint. Concordantly, attention has turned to new treatment strategies regarding hepatitis C virus recurrence after liver and renal transplantation. The addition of oral direct acting antivirals to the existing treatment marks a promising strategy for prognosis amelioration of these patients.
Publish Date	2014-05-27 11:34
Citation	Pipili C, Cholongitas E. Μanagement of patients with hepatitis B and C before and after liver and kidney transplantation. World J Hepatol 2014; 6(5): 315-325
URL	http://www.wjgnet.com/1948-5182/full/v6/i5/315.htm
DOI	http://dx.doi.org/10.4254/wjh.v6.i5.315

Full Article (PDF)	WJH-6-315.pdf
Full Article (Word)	WJH-6-315.doc
Manuscript File	7858-Review.doc
Answering Reviewers	7858-Answering reviewers.pdf
Copyright License Agreement	7858-Copyright assignment.pdf
Peer-review Report	7858-Peer review(s).pdf
Scientific Editor Work List	7858-Scientific editor work list.doc